NEOCHORD
NeoChord is a medical device company that has developed a proprietary device that allows mitral valve repair to be performed on a beating heart through a 2 to 3-inch incision between the ribs in patients with severe, degenerative mitral valve regurgitation. In contrast, most mitral valve repair procedures are performed through a 3 to 10-inch chest incision (sternotomy) which involves cutting through the sternum, opening the rib cage, stopping the heart and placing the patient on bypass. Founded in 2007 and is based in St. Louis Park, MN.
NEOCHORD
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2007-01-01
Address:
Saint Louis Park, Minnesota, United States
Country:
United States
Website Url:
http://www.neochord.com
Total Employee:
11+
Status:
Active
Contact:
952-698-7800
Total Funding:
89.89 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network Wordpress Plugins
Current Advisors List
Current Employees Featured
Founder
Investors List
Treo Ventures
Treo Ventures investment in Series D - NeoChord
U.S. Venture Partners
U.S. Venture Partners investment in Series D - NeoChord
Baird Capital
Baird Capital investment in Series D - NeoChord
Deerfield Capital Management
Deerfield Capital Management investment in Series D - NeoChord
Heron Capital
Heron Capital investment in Series C - NeoChord
Baird Capital
Baird Capital investment in Series C - NeoChord
CHV Capital
CHV Capital investment in Series C - NeoChord
Deerfield
Deerfield investment in Series C - NeoChord
Hopen Life Science Ventures
Hopen Life Science Ventures investment in Series C - NeoChord
TGap Ventures
TGap Ventures investment in Series C - NeoChord
Official Site Inspections
http://www.neochord.com
- Host name: neochord.wpmudev.host
- IP address: 149.28.198.88
- Location: San Jose United States
- Latitude: 37.3387
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95113
More informations about "NeoChord"
Home | NeoChord
NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. NeoChord …See details»
About Us - NeoChord
NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company’s …See details»
Healthcare Professionals - NeoChord
The NeoChord procedure is a beating heart, echo-guided treatment option for patients with mitral valve regurgitation and is proven to resolve and restore normal mitral valve function. The NeoChord DS1000 System is intended for …See details»
NeoChord - Crunchbase Company Profile & Funding
NeoChord is a medical device company that has developed a proprietary device that allows mitral valve repair to be performed on a beating heart through a 2 to 3-inch incision between the ribs in patients with severe, degenerative mitral …See details»
NeoChord Company Profile 2024: Valuation, Funding & Investors
Developer of a mitral valve repair tool designed for patients suffering from severe mitral regurgitation due to leaflet prolapse.See details»
Org Chart NeoChord - The Official Board
The organizational chart of NeoChord displays its 13 main executives including Todd Berg, Ron Nelson and Kavitha GanesanSee details»
NeoChord, Inc. Company Profile | Maple Grove, MN | Competitors ...
Find company research, competitor information, contact details & financial data for NeoChord, Inc. of Maple Grove, MN. Get the latest business insights from Dun & Bradstreet.See details»
NeoChord Inc - Radcliffe Cardiology
NeoChord, Inc., a venture backed medical device company, is investigating minimally invasive technology intended to transform the treatment of degenerative mitral regurgitation.See details»
NeoChord Company Profile - Office Locations, Competitors ... - Craft
NeoChord is a medical device company that has developed a proprietary device that allows mitral valve repair to be performed on a beating heart through a 2 to 3 inch incision between the ribs …See details»
Contact Us - NeoChord
Please email us at [email protected] and we will get back to you as soon as possible. NeoChord is a privately held medical technology company leading the advancement of beating …See details»
NeoChord Announces Positive 1-year Follow-Up Data with
Oct 19, 2022 · NeoChord announced today positive results on the first, 1-year follow up patient in the Company’s Global Early Feasibility Study (EFS) treated with the novel Transcatheter …See details»
NeoChord Announces Successful Completion of First in Human
Oct 4, 2021 · NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The …See details»
Neochords: How long, how many, too many? - PMC - National …
Oct 28, 2023 · In this article, we describe our approach to neochordal repair of the myxomatous mitral valve based on biomechanical ex vivo and large animal translational research performed …See details»
NeoChord Announces Positive 1-year Follow-Up Data with …
Oct 19, 2022 · NeoChord announced today positive results on the first, 1-year follow up patient in the Company’s Global Early Feasibility Study (EFS) treated with the novel Transcatheter …See details»
Patient Education - NeoChord
NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. NeoChord …See details»
NeoChord Announces Positive 30-day Results with Transcatheter …
Nov 22, 2021 · “As the first successful multiple-chord to a single anchor procedure worldwide, these 30-day results demonstrate how the NeXuS System can be used as front-line therapy …See details»
Initial Experience With a New Mitral Ring Designed to Simplify …
Many techniques have been described, with the goal of optimizing neochord implantation. A new annuloplasty device designed to simplify the determination of the appropriate neochord length …See details»
NeoChord’s Nexus Mitral Chordal Repair Procedure Using Multiple …
Nov 22, 2021 · According to the company, the investigational Nexus device is designed to restore function in patients with severe symptomatic primary mitral regurgitation (MR) while …See details»
News - NeoChord
NeoChord Appoints Martin B. Leon, M.D. as Executive Chair of the U.S. Early Feasibility Study of the NeoChord Transcatheter NeXuS System. David H. Adams, MD and Michael A. Borger, …See details»
Neochords: How long, how many, too many? - JTCVS ... - JTCVS …
Aug 8, 2023 · In this article, we describe our approach to neochordal repair of the myxomatous mitral valve based on biomechanical ex vivo and large animal translational research performed …See details»